How Much Longer Should You Hold Shares of Valeant Pharmaceuticals Intl Inc.?

Bill Ackman is walking away from Valeant Pharmaceuticals Intl Inc (TSX:VRX)(NYSE:VRX). Should you?

| More on:
The Motley Fool

Over the past few weeks, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have been in the news … again. The most recent reason Valeant was in the news was because well-known hedge fund manager Bill Ackman announced that he and another representative would be walking away from the investment, effectively leaving the board of directors once their terms were up.

Since investors have had a few weeks to digest the news and observe the share price decline in value (yet again), we can now step back and ask ourselves what this means for Valeant.

Mr. Ackman has an incredible track record for getting things done while making a splash in the media. Although he is 36 years younger than Warren Buffett, he has probably spent as much time (if not more time) in front of the camera than Mr. Buffett.

As an investor in Valeant, Mr. Ackman brought a lot of attention with him. He also brought confidence and the ability to rally people to reach an end goal. With Valeant, the end goal was to reach a point where it would be sustainable to pay the company’s interest expenses given the revenues that came through the front door.

With the company spending between 15% and 20% of revenues on interest expenses and bondholders losing faith, there is little reason to relax the covenants. Going forward, it would be completely understandable to see the bondholders force the company’s hand if push comes to shove.

Shares of Valeant made up a significant amount of Mr. Ackman’s portfolio several years ago; the reality is, a market decline not only wipes out the value of an investment but also the entire portfolio. Investors need to realize what it means to lose money and to make it back.

Take Hot Stock A as an example. We invest 50% of our portfolio into the stock. Hot Stock A represents $50,000 and 19 other securities represent $50,000 of the entire portfolio. Assuming 19 stocks do not move and Hot Stock A declines by 90%, then the entire portfolio is now worth $55,000, and the holding accounts for 9.1% of the portfolio.

A 90% decline in value changed the value of the stock by 90%, but the weighting moved from 50% to 9.1%. As investors, we obviously want securities that make up a bigger part of a larger portfolio instead of the above situation.

This is why Mr. Ackman hung in for so long.

Barring a major cash injection into the company, there is simply too much debt and not enough revenues to cover the company’s long-term financial solvency issues. Investors need to ask themselves: “Just how much longer will I hold on to this sick puppy?”

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Goldsman has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

money cash dividends
Stocks for Beginners

Where to Invest $10,000 in April 2024

If you've already created a diversified portfolio and are looking for more options from a windfall, here is where I…

Read more »

data analyze research
Investing

The Ultimate TSX Stock to Buy With $1,000 Right Now

Brookfield Asset Management (TSX:BAM) is one of the best Canadian stocks to buy for those looking to put capital to…

Read more »

young woman celebrating a victory while working with mobile phone in the office
Dividend Stocks

3 CRA Benefits Most Canadians Can Grab in 2024

You can save on taxes by claiming the dividend tax credit on Fortis Inc (TSX:FTS) shares.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »